A new docetaxel (D) gemcitabine (G) regimen as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): A phase II study.

被引：0
|
作者：
Morere, JF
Terrioux, P
Brechot, JM
Tredaniel, J
Bouchahda, M
Duhamel, JP
Mandet, J
Brain, E
Beerblock, K
Fellague, R
机构：
[1] Univ Paris 13, CHU Avicenne, Bobigny, France
[2] GERCOR, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：692S / 692S
页数：1
相关论文
共 50 条
  • [1] Biweekly docetaxel and gemcitabine as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Gaspar, E.
    Firvida, J.
    Amenedo, M.
    Orts, D.
    Salgado, M.
    LLorca, C.
    Ramos, M.
    Perez, E.
    Cervera, J.
    Abal, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Phase I/II trial of docetaxel (D) and Carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Giannakakis, T
    Papadouris, S
    Kourousis, C
    Kalbakis, NK
    Tzianni, V
    Lidaki, E
    Androulakis, N
    Souklakos, J
    Sarra, E
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 94
  • [3] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer:: a lung cancer Galician group phase II study
    Casal, Joaquin
    Amenedo, Margarita
    Mel, Jose Ramon
    Anton, Luis Miguel
    Rodriguez-Lopez, Ruben
    Lopez-Lopez, Rafael
    Gonzalez-Ageitos, Ana
    Castellanos, Javier
    Constenla, Manuel
    Tisaire, Jose L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 725 - 732
  • [4] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study
    Joaquín Casal
    Margarita Amenedo
    José Ramón Mel
    Luis Miguel Antón
    Rubén Rodríguez-López
    Rafael López-López
    Ana González-Ageitos
    Javier Castellanos
    Manuel Constenla
    José L. Tisaire
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 725 - 732
  • [5] Weekly docetaxel-gemcitabine as first-line treatment in advanced non-small cell lung cancer: Preliminary results of a phase II study.
    Kalmadi, SR
    Mekhail, T
    Adelstein, D
    Giannini, C
    Peereboom, D
    Olencki, T
    Davis, M
    Bukowski, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 675S - 675S
  • [6] Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Benk, J
    Chemaissani, A
    Scholtze, J
    Lorenz, C
    Niestroy, A
    Dalhoff, K
    Müller, T
    Walter, T
    Dürk, H
    Edler, L
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) : 583 - 590
  • [7] Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer
    Chiappori, A
    Simon, G
    Williams, C
    Haura, E
    Rocha-Lima, C
    Wagner, H
    Bepler, G
    Antonia, S
    ONCOLOGY, 2005, 68 (4-6) : 382 - 390
  • [8] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [9] Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in elderly non-small cell lung cancer (NSCLC) patients.
    Llorca, C.
    Esquerdo, G.
    Munoz, J., Sr.
    Sanchez-Hernandez, A.
    Gomez-Codina, J.
    Juan Vidal, O.
    Macia, S.
    Catot, S.
    Giner, V.
    Aparisi, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kasai, Hisashi
    Kodama, Tetsuro
    CHEMOTHERAPY, 2012, 58 (01) : 78 - 83
12345